Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present four abstracts at the 2025 American Society for Radiation Oncology Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback